Effects of 5α-cholestan-3-one on the synaptic vesicle cycle at the mouse neuromuscular junction

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1851, Issue 5, 2015, Pages 674-685

  Kasimov, M R ^a   Giniatullin, A R ^a   Zefirov, A L ^a   Petrov, A M ^a  

^a KAZAN STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

5 cholestan 3 one; Cholesterol; Lipid raft; Neuromuscular junction; Neurotransmitter release; Synaptic vesicle cycle

Indexed keywords

5 ALPHA CHOLESTAN 3 ONE; CHOLERA TOXIN; CHOLESTEROL DERIVATIVE; UNCLASSIFIED DRUG; CHOLESTANE DERIVATIVE; CHOLESTEROL; COPROSTANONE; FLUORESCENT DYE; FM1 43; PYRIDINIUM DERIVATIVE; QUATERNARY AMMONIUM DERIVATIVE;

ACTION POTENTIAL; ANIMAL CELL; ARTICLE; CELL POPULATION; CONTROLLED STUDY; EXOCYTOSIS; FLUORESCENCE; MOUSE; NERVE STIMULATION; NEUROMUSCULAR SYNAPSE; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN SECRETION; SYNAPSE VESICLE; SYNAPTIC TRANSMISSION; ANIMAL; CELL MEMBRANE; DIAPHRAGM; DRUG EFFECTS; ELECTROSTIMULATION; IN VITRO STUDY; INNERVATION; METABOLISM; MINIATURE ENDPLATE POTENTIAL; PHRENIC NERVE; SYNAPTOSOME; TIME;

ANIMALS; CELL MEMBRANE; CHOLESTANES; CHOLESTEROL; DIAPHRAGM; ELECTRIC STIMULATION; EXOCYTOSIS; FLUORESCENT DYES; IN VITRO TECHNIQUES; MEMBRANE MICRODOMAINS; MICE; MINIATURE POSTSYNAPTIC POTENTIALS; NEUROMUSCULAR JUNCTION; PHRENIC NERVE; PRESYNAPTIC TERMINALS; PYRIDINIUM COMPOUNDS; QUATERNARY AMMONIUM COMPOUNDS; SYNAPTIC TRANSMISSION; SYNAPTIC VESICLES; TIME FACTORS;

EID: 84923872629     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2015.02.012     Document Type: Article

References (44)

1. S.O. Rizzoli, and W.J. Betz Synaptic vesicle pools Nat. Rev. Neurosci. 6 2005 57 69 10.1038/nrn1583
2. A.A. Alabi, and R.W. Tsien Synaptic vesicle pools and dynamics Cold Spring Harb. Perspect. Biol. 4 2012 a013680 10.1146/annurev-physiol-020911-153305
3. D.A. Richards, C. Guatimosim, S.O. Rizzoli, and W.J. Betz Synaptic vesicle pools at the frog neuromuscular junction Neuron 39 2003 529 541
4. T.C. Sudhof The synaptic vesicle cycle Annu. Rev. Neurosci. 27 2004 509 547 10.1146/annurev.neuro.26.041002.131412
5. D. Puchkov, and V. Haucke Greasing the synaptic vesicle cycle by membrane lipids Trends Cell Biol. 23 2013 493 503 10.1016/j.tcb.2013.05.002
6. A.M. Petrov, and A.L. Zefirov Cholesterol and lipid rafts in the biological membranes. Role in the release, reception and ion channel functions Usp. Fiziol. Nauk 44 2013 17 38
7. A.M. Sebastião, M. Colino-Oliveira, N. Assaife-Lopes, R.B. Dias, and J.A. Ribeiro Lipid rafts, synaptic transmission and plasticity: impact in age-related neurodegenerative diseases Neuropharmacology 64 2013 97 107 10.1016/j.neuropharm.2012.06.053
8. R. Kuver Mechanisms of oxysterol-induced disease: insights from the biliary system Clin. Lipidol. 7 2012 537 548 10.2217/clp.12.53
9. A.O. Sodero, C. Weissmann, M.D. Ledesmac, and C.G. Dotti Cellular stress from excitatory neurotransmission contributes to cholesterol loss in hippocampal neurons aging in vitro Neurobiol. Aging 32 2011 1043 1053
10. A.M. Petrov, A.A. Yakovleva, and A.L. Zefirov Role of membrane cholesterol in spontaneous exocytosis at frog neuromuscular synapses: ROS calcium interplay J. Physiol. 592 2014 4995 5009 10.1113/jphysiol.2014.279695
11. V. Leoni, and C. Caccia Oxysterols as biomarkers in neurodegenerative diseases Chem. Phys. Lipids 164 2011 515 524 10.1016/j.chemphyslip.2011.04.002
12. S.M. Paul, J.J. Doherty, A.J. Robichaud, G.M. Belfort, B.Y. Chow, R.S. Hammond, D.C. Crawford, A.J. Linsenbardt, H.J. Shu, Y. Izumi, S.J. Mennerick, and C.F. Zorumski The major brain cholesterol metabolite 24(S)-hydroxycholesterol is a potent allosteric modulator of N-methyl-D-aspartate receptors J. Neurosci. 33 2013 17290 17300 10.1523/JNEUROSCI.2619-13.2013
13. A.M. Petrov, M.R. Kasimov, A.R. Giniatullin, and A.L. Zefirov Effects of oxidation of membrane cholesterol on the vesicle cycle in motor nerve terminals in the frog Rana Ridibunda Neurosci. Behav. Physiol. 44 2014 1020 1030 10.1007/s11055-014-0019-y
14. J.H. Menkes, J.R. Schimschock, and P.D. Swanson Cerebrotendinous xanthomatosis. The storage of cholestanol within the nervous system Arch. Neurol. 19 1968 47 53 10.1001/archneur.1968.00480010065004
15. A. Båvner, M. Shafaati, M. Hansson, M. Olin, S. Shpitzen, V. Meiner, E. Leitersdorf, and I. Björkhem On the mechanism of accumulation of cholestanol in the brain of mice with a disruption of sterol 27-hydroxylase J. Lipid Res. 51 2010 2722 2730 10.1194/jlr.M008326
16. G. Salen, and A. Polito Biosynthesis of 5-cholestan-3-ol in cerebrotendinous xanthomatosis J. Clin. Invest. 51 1972 134 140 10.1172/jci106783
17. A.E. DeBarber, Y. Sandlers, A.S. Pappu, L.S. Merkens, P.B. Duell, S.R. Lear, S.K. Erickson, and R.D. Steiner Profiling sterols in cerebrotendinous xanthomatosis: utility of Girard derivatization and high resolution exact mass LC-ESI-MS(n) analysis J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 879 2011 1384 1392 10.1016/j.jchromb.2010.11.019
18. I. Björkhem Cerebrotendinous xanthomatosis Curr. Opin. Lipidol. 24 2013 283 287 10.1097/MOL.0b013e328362df13
19. A.R. Giniatullin, S.N. Grishin, E.R. Sharifullina, A.M. Petrov, A.L. Zefirov, and R.A. Giniatullin Reactive oxygen species contribute to the presynaptic action of extracellular ATP at the frog neuromuscular junction J. Physiol. 565 2005 229 242 10.1113/jphysiol.2005.084186
20. W.J. Betz, and G.S. Bewick Optical monitoring of transmitter release and synaptic vesicle recycling at the frog neuromuscular junction J. Physiol. 460 1993 287 309
21. A.M. Petrov, N.V. Naumenko, K.V. Uzinskaya, A.R. Giniatullin, A.K. Urazaev, and A.L. Zefirov Increased non-quantal release of acetylcholine after inhibition of endocytosis by methyl-β-cyclodextrin: the role of vesicular acetylcholine transporter Neuroscience 186 2011 1 12 10.1016/j.neuroscience.2011.04.051
22. A.M. Petrov, A.R. Giniatullin, G.F. Sitdikova, and A.L. Zefirov The role of cGMP-dependent signaling pathway in synaptic vesicle cycle at the frog motor nerve terminals J. Neurosci. 28 2008 13216 13222 10.1523/JNEUROSCI.2947-08.2008
23. R. Rea, J. Li, A. Dharia, E.S. Levitan, P. Sterling, and R.H. Kramer Streamlined synaptic vesicle cycle in cone photoreceptor terminals Neuron 41 2004 755 766 10.1016/S0896-6273(04)00088-1
24. C. Schwan, T. Nölke, A.S. Kruppke, D.M. Schubert, A.E. Lang, and K. Aktories Cholesterol- and sphingolipid-rich microdomains are essential for microtubule-based membrane protrusions induced by Clostridium difficile transferase (CDT) J. Biol. Chem. 286 2011 29356 29365 10.1074/jbc.M111.261925
25. G. Margheri, R. D'Agostino, S. Trigari, S. Sottini, and M. Del Rosso The β-subunit of cholera toxin has a high affinity for ganglioside GM1 embedded into solid supported lipid membranes with a lipid raft-like composition Lipids 49 2014 203 206 10.1007/s11745-013-3845-8
26. N. Blank, M. Schiller, S. Krienke, G. Wabnitz, A.D. Ho, and H.M. Lorenz Cholera toxin binds to lipid rafts but has a limited specificity for ganglioside GM1 Immunol. Cell Biol. 85 2007 378 382
27. L.M. Loura, A. Fedorov, and M. Prieto Exclusion of a cholesterol analog from the cholesterol-rich phase in model membranes Biochim. Biophys. Acta 1511 2001 236 243 10.1016/S0005-2736(01)00269-3
28. P. Ostašov, J. Sýkora, J. Brejchová, A. Olzyńska, M. Hof, and P. Svoboda FLIM studies of 22- and 25-NBD-cholesterol in living HEK293 cells: plasma membrane change induced by cholesterol depletion Chem. Phys. Lipids 62-9 2013 167 168 10.1016/j.chemphyslip.2013.02.006
29. S.J. Hong, and C.C. Chang Use of geographutoxin II (mu-conotoxin) for the study of neuromuscular transmission in mouse Br. J. Pharmacol. 97 1989 934 940 (PMID: 2547492)
30. Y. Liu, Y. Sugiura, and W. Lin The role of synaptobrevin1/VAMP1 in Ca2 + - triggered neurotransmitter release at the mouse neuromuscular junction J. Physiol. 589 2011 1603 1618 10.1113/jphysiol.2010.201939
31. A.L. Zefirov, A.V. Zakharov, R.D. Mukhametzyanov, A.M. Petrov, and G.F. Sitdikova The vesicle cycle in motor nerve endings of the mouse diaphragm Neurosci. Behav. Physiol. 39 2009 245 252 10.1007/s11055-009-9122-x
32. B. Reid, C.R. Slater, and G.S. Bewick Synaptic vesicle dynamics in rat fast and slow motor nerve terminals J. Neurosci. 19 1999 2511 2521
33. O. Zamir, and M.P. Charlton Cholesterol and synaptic transmitter release at crayfish neuromuscular junctions J. Physiol. 571 2006 83 99 10.1113/jphysiol.2005.098319
34. G. Teixeira, L.B. Vieira, M.V. Gomez, and C. Guatimosim Cholesterol as a key player in the balance of evoked and spontaneous glutamate release in rat brain cortical synaptosomes Neurochem. Int. 61 2012 1151 1159 10.1016/j.neuint.2012.08.008
35. D.M. Ramirez, and E.T. Kavalali Differential regulation of spontaneous and evoked neurotransmitter release at central synapses Curr. Opin. Neurobiol. 21 2011 275 282 10.1016/j.conb.2011.01.007 (Epub 2011 Feb 18)
36. N.B. Fredj, and J. Burrone A resting pool of vesicles is responsible for spontaneous vesicle fusion at the synapse Nat. Neurosci. 12 2009 751 775 10.1038/nn.2317
37. A. Gnanasekaran, M. Sundukova, A.M. van den Maagdenberg, E. Fabbretti, and A. Nistri Lipid rafts control P2X3 receptor distribution and function in trigeminal sensory neurons of a transgenic migraine mouse model Mol. Pain 7 2011 1 13 10.1186/1744-8069-7-77
38. J.J. Mackrill Oxysterols and calcium signal transduction Chem. Phys. Lipids 164 2011 488 495 10.1016/j.chemphyslip.2011.04.001
39. M. Weber-Boyvat, W. Zhong, D. Yan, and V.M. Olkkonen Oxysterol-binding proteins: functions in cell regulation beyond lipid metabolism Biochem. Pharmacol. 86 2013 89 95 10.1016/j.bcp.2013.02.016
40. A.M. Petrov, M.R. Kasimov, A.R. Giniatullin, O.I. Tarakanova, and A.L. Zefirov The role of cholesterol in the exo- and endocytosis of synaptic vesicles in frog motor nerve endings Neurosci. Behav. Physiol. 40 2010 894 901 10.1007/s11055-010-9338-9
41. K. Simons, and J.L. Sampaio Membrane organization and lipid rafts Cold Spring Harb. Perspect. Biol. 3 2011 a004697 10.1101/cshperspect.a004697
42. C.J. Loewen, A. Roy, and T.P. Levine A conserved ER targeting motif in three families of lipid binding proteins and in Opi1p binds VAP EMBO J. 22 2003 2025 2035 10.1093/emboj/cdg201
43. T. Vihervaara, M. Jansen, R.L. Uronen, Y. Ohsaki, E. Ikonen, and V.M. Olkkonen Cytoplasmic oxysterol-binding proteins: sterol sensors or transporters? Chem. Phys. Lipids 164 2011 443 450 10.1016/j.chemphyslip.2011.03.002
44. N. Rocha, C. Kuijl, R. van der Kant, L. Janssen, D. Houben, H. Janssen, W. Zwart, and J. Neefjes Cholesterol sensor ORP1L contacts the ER protein VAP to control Rab7-RILP-p150 Glued and late endosome positioning J. Cell Biol. 185 2009 1209 1225 10.1083/jcb.200811005